adplus-dvertising
Connect with us

Health

'Vaccine nationalism': Is it every country for itself? – The Province

Published

 on


A small bottle labeled with a “Vaccine” sticker is held near a medical syringe in front of displayed “Coronavirus COVID-19” words in this illustration taken April 10, 2020.

Dado Ruvic / REUTERS

LONDON/CHICAGO — It’s dog eat dog in the world of COVID-19 vaccines.

That’s the fear of global health agencies planning a scheme to bulk-buy and equitably distribute vaccines around the world. They are watching with dismay as some wealthier countries have decided to go it alone, striking deals with drugmakers to secure millions of doses of promising candidates for their citizens.

The deals – including those agreed by the United States, Britain and the European Union with the likes of Pfizer, BioNtech, AstraZeneca and Moderna – are undermining the global drive, experts say.

“Everybody doing bilateral deals is not a way to optimize the situation,” said Seth Berkley, chief executive of the GAVI alliance which co-leads the scheme called COVAX designed to secure rapid and fair global access to COVID-19 vaccines.

Pfizer said this week it was in concurrent talks with the EU and several of its member states on supplying them with its potential vaccine.

And in the latest swoop, Britain announced a deal on Wednesday to secure advanced supplies of potential COVID-19 vaccines from GlaxoSmithKline and Sanofi.

This, according to global health charity Medecins Sans Frontieres (MSF), will further fuel “the global scramble to hoard vaccines by rich countries” and feed “a dangerous trend of vaccine nationalism.”

The concern is that vaccine supply and allocation in this pandemic will echo the last – caused by the H1N1 flu virus in 2009/2010 – when rich nations bought up the available supply of vaccines, initially leaving poor countries with none.

In that instance, since H1N1 turned out to be a milder disease and the pandemic ultimately petered out, the impact on infections and deaths from vaccine imbalances was limited.

However COVID-19 is a far greater threat, and leaving swathes of the world’s people vulnerable will not only harm them, but also extend the pandemic and the damage it can cause, health experts say.

“There is a risk that some countries are doing exactly what we feared – which is every man for himself,” said Gayle Smith, former head of the U.S. Agency for International Development and CEO of the One Campaign, a non-profit aimed at ending poverty and preventable disease.

‘I AM WORRIED’

More than 75 wealthier countries including Britain have expressed interest in the COVAX financing scheme, which is also co-led by the World Health Organization and the Coalition for Epidemic Preparedness Innovations, or CEPI, joining 90 poorer ones who would be supported through donations.

But the United States, China and Russia are not among countries expressing interest in COVAX, according to GAVI.

And an EU source said last week that the European Commission, which is the bloc’s executive arm and leads EU talks with drugmakers, has advised EU countries not to buy COVID-19 vaccines via COVAX.

“I am worried,” said Thomas Bollyky, director of the global health program at the Council on Foreign Relations. “What is happening with the handful of nations that are locking up supply of vaccine competes with the multilateral supply deals.

“At the end of the day, vaccine manufacturing is a finite resource. You can expand it, but only so much.”

Experts estimate the world can reasonably hope to have around 2 billion doses of effective COVID-19 vaccines by the end of next year, if several of the leading candidates prove effective in expedited late-stage trials currently underway. COVAX’s aim is to distribute doses for at least 20% of its signed-up countries’ populations.

ANOTHER TWO YEARS?

Berkley of GAVI said, however, that if self-interested countries or regions snapped those up to cover their entire populations – instead of sharing them across nations and protecting the most at-risk people first – the pandemic could not be controlled.

“If you were to try to vaccinate the entire U.S., (and) the entire EU, for example, with two doses of vaccine – then you’d get to about 1.7 billion doses. And if that is the number of doses that’s available, there’s not a lot left for others.”

If a handful, or even 30 or 40 countries have vaccines, but more than 150 others don’t, “then the epidemic will rage there” Berkley said.

“This virus … moves around like lightning. So you’ll end up in a situation where you will not be able to go back to normal. You won’t be able to have commerce, tourism, travel, trade, unless you can get the whole pandemic to be slowed down.”

He and Smith and other health experts said ending the pandemic meant ending it globally.

“It’s the difference from a pandemic (for) another two years as opposed to one year,” Smith added. “The economics and health consequences of that are enormous.” (Reporting by Kate Kelland in London and Julie Steenhuysen in Chicago; Editing by Pravin Char)

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

Health

Canada to donate up to 200,000 vaccine doses to combat mpox outbreaks in Africa

Published

 on

 

The Canadian government says it will donate up to 200,000 vaccine doses to fight the mpox outbreak in Congo and other African countries.

It says the donated doses of Imvamune will come from Canada’s existing supply and will not affect the country’s preparedness for mpox cases in this country.

Minister of Health Mark Holland says the donation “will help to protect those in the most affected regions of Africa and will help prevent further spread of the virus.”

Dr. Madhukar Pai, Canada research chair in epidemiology and global health, says although the donation is welcome, it is a very small portion of the estimated 10 million vaccine doses needed to control the outbreak.

Vaccine donations from wealthier countries have only recently started arriving in Africa, almost a month after the World Health Organization declared the mpox outbreak a public health emergency of international concern.

A few days after the declaration in August, Global Affairs Canada announced a contribution of $1 million for mpox surveillance, diagnostic tools, research and community awareness in Africa.

On Thursday, the Africa Centres for Disease Control and Prevention said mpox is still on the rise and that testing rates are “insufficient” across the continent.

Jason Kindrachuk, Canada research chair in emerging viruses at the University of Manitoba, said donating vaccines, in addition to supporting surveillance and diagnostic tests, is “massively important.”

But Kindrachuk, who has worked on the ground in Congo during the epidemic, also said that the international response to the mpox outbreak is “better late than never (but) better never late.”

“It would have been fantastic for us globally to not be in this position by having provided doses a much, much longer time prior than when we are,” he said, noting that the outbreak of clade I mpox in Congo started in early 2023.

Clade II mpox, endemic in regions of West Africa, came to the world’s attention even earlier — in 2022 — as that strain of virus spread to other countries, including Canada.

Two doses are recommended for mpox vaccination, so the donation may only benefit 100,000 people, Pai said.

Pai questioned whether Canada is contributing enough, as the federal government hasn’t said what percentage of its mpox vaccine stockpile it is donating.

“Small donations are simply not going to help end this crisis. We need to show greater solidarity and support,” he said in an email.

“That is the biggest lesson from the COVID-19 pandemic — our collective safety is tied with that of other nations.”

This report by The Canadian Press was first published Sept. 13, 2024.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

How many Nova Scotians are on the doctor wait-list? Number hit 160,000 in June

Published

 on

 

HALIFAX – The Nova Scotia government says it could be months before it reveals how many people are on the wait-list for a family doctor.

The head of the province’s health authority told reporters Wednesday that the government won’t release updated data until the 160,000 people who were on the wait-list in June are contacted to verify whether they still need primary care.

Karen Oldfield said Nova Scotia Health is working on validating the primary care wait-list data before posting new numbers, and that work may take a matter of months. The most recent public wait-list figures are from June 1, when 160,234 people, or about 16 per cent of the population, were on it.

“It’s going to take time to make 160,000 calls,” Oldfield said. “We are not talking weeks, we are talking months.”

The interim CEO and president of Nova Scotia Health said people on the list are being asked where they live, whether they still need a family doctor, and to give an update on their health.

A spokesperson with the province’s Health Department says the government and its health authority are “working hard” to turn the wait-list registry into a useful tool, adding that the data will be shared once it is validated.

Nova Scotia’s NDP are calling on Premier Tim Houston to immediately release statistics on how many people are looking for a family doctor. On Tuesday, the NDP introduced a bill that would require the health minister to make the number public every month.

“It is unacceptable for the list to be more than three months out of date,” NDP Leader Claudia Chender said Tuesday.

Chender said releasing this data regularly is vital so Nova Scotians can track the government’s progress on its main 2021 campaign promise: fixing health care.

The number of people in need of a family doctor has more than doubled between the 2021 summer election campaign and June 2024. Since September 2021 about 300 doctors have been added to the provincial health system, the Health Department said.

“We’ll know if Tim Houston is keeping his 2021 election promise to fix health care when Nova Scotians are attached to primary care,” Chender said.

This report by The Canadian Press was first published Sept. 11, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

Newfoundland and Labrador monitoring rise in whooping cough cases: medical officer

Published

 on

 

ST. JOHN’S, N.L. – Newfoundland and Labrador‘s chief medical officer is monitoring the rise of whooping cough infections across the province as cases of the highly contagious disease continue to grow across Canada.

Dr. Janice Fitzgerald says that so far this year, the province has recorded 230 confirmed cases of the vaccine-preventable respiratory tract infection, also known as pertussis.

Late last month, Quebec reported more than 11,000 cases during the same time period, while Ontario counted 470 cases, well above the five-year average of 98. In Quebec, the majority of patients are between the ages of 10 and 14.

Meanwhile, New Brunswick has declared a whooping cough outbreak across the province. A total of 141 cases were reported by last month, exceeding the five-year average of 34.

The disease can lead to severe complications among vulnerable populations including infants, who are at the highest risk of suffering from complications like pneumonia and seizures. Symptoms may start with a runny nose, mild fever and cough, then progress to severe coughing accompanied by a distinctive “whooping” sound during inhalation.

“The public, especially pregnant people and those in close contact with infants, are encouraged to be aware of symptoms related to pertussis and to ensure vaccinations are up to date,” Newfoundland and Labrador’s Health Department said in a statement.

Whooping cough can be treated with antibiotics, but vaccination is the most effective way to control the spread of the disease. As a result, the province has expanded immunization efforts this school year. While booster doses are already offered in Grade 9, the vaccine is now being offered to Grade 8 students as well.

Public health officials say whooping cough is a cyclical disease that increases every two to five or six years.

Meanwhile, New Brunswick’s acting chief medical officer of health expects the current case count to get worse before tapering off.

A rise in whooping cough cases has also been reported in the United States and elsewhere. The Pan American Health Organization issued an alert in July encouraging countries to ramp up their surveillance and vaccination coverage.

This report by The Canadian Press was first published Sept. 10, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending